P 829

amino acid sequence in first source

Also Known As:

Lys-Cys-Lys-(beta-DAP)-CH2CO-S-cyclo(hCys-(N-Me)Phe-Tyr-Trp-Lys-Val); P-829; P829 cpd; lysyl-cysteinyl-lysyl-(beta-DAP) cyclo(homocysteinyl-(N-methyl)phenylalanyl-tyrosyl-tryptophyl-lysyl-valyl)thiomethyl ketone

Networked: 4 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - P 829: 4
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - P 829: 4

Experts

1.	Colley, Ryan: 1 article (02/2021)
2.	Levy, Jonathan C: 1 article (02/2021)
3.	Polisetty, Teja S: 1 article (02/2021)
4.	Li, Bin: 1 article (05/2019)
5.	Li, Bo: 1 article (05/2019)
6.	Luo, Fuliang: 1 article (05/2019)
7.	Luo, Xiaokang: 1 article (05/2019)
8.	Qi, Lei: 1 article (05/2019)
9.	Tang, Yue: 1 article (05/2019)
10.	Zhang, Dong: 1 article (05/2019)

Related Diseases

1.	Insulin Resistance 01/10/2023 - "Insulin resistance (HOMA-IR) improved after disease control of acromegaly (P < .000) and remained unaltered after GH replacement in the GHD patients (P = .829). "
2.	Acromegaly 01/10/2023 - "Insulin resistance (HOMA-IR) improved after disease control of acromegaly (P < .000) and remained unaltered after GH replacement in the GHD patients (P = .829). "
3.	Thrombosis (Thrombus) 02/01/2016 - "and Asian patients were similar, including primary patency (82.9% vs 83.0%; P = .889), clinically driven target lesion revascularization (13.4% vs 11.7%; P = .829), stent fracture rate (1.3% vs 0.0%; P = 1.000), and stent thrombosis rate (0.5% vs 0.0%; P = 1.000). "
4.	Pain (Aches) 02/01/2021 - "At the final follow-up, we found no significant differences in PROMs, including the Simple Shoulder Test score (P = .829), American Shoulder and Elbow Surgeons score (P = .601), visual analog scale pain score (P = .068), and Single Assessment Numeric Evaluation score (P = .674). "
5.	Fibrosis (Cirrhosis) 05/01/2019 - "A negative correlation was identified between fibrosis and conduction velocity (P<.001 in the 3-month and 6-month groups), but no correlation was found between fibrosis and the effective refractory period (P=.829 in the 3-month group and P=.093 in the 6-month group). "

Related Therapies and Procedures

1.	Stents